Table 1

Clinical characteristics of gastric cancer patients and Sp1 expression

The two-tailed χ2 test was performed using SPSS software.

Case (%) (n = 86)Sp1 stainingP
Negative (n = 17)Weak (n = 48)Strong (n = 21)
Age
 ≤6039 (45.3)11 (28.2)21 (53.8)7 (17.9)
 >6047 (54.7)6 (12.8)27 (57.4)14 (29.8)0.146
Sex
 F30 (34.9)8 (26.7)15 (50.0)7 (23.3)
 M56 (65.1)9 (16.1)33 (58.9)14 (25.0)0.494
Stage
 I14 (16.3)4 (28.6)8 (57.1)2 (14.3)
 II28 (32.6)5 (17.9)18 (64.3)5 (17.9)
 III30 (34.9)5 (16.7)15 (50.0)10 (33.3)
 IV14 (16.3)3 (21.4)7 (50.0)4 (28.6)0.737
Pathology type
 Papillary12 (14.0)2 (16.7)6 (50.0)4 (33.3)
 Tubular28 (32.6)7 (25.0)16 (57.1)5 (17.9)
 Diffuse8 (9.3)1 (12.5)3 (37.5)4 (50.0)
 Mucinous5 (5.8)1 (20.0)4 (80.0)0 (00.0)
 Signet ring21 (24.4)6 (28.6)11 (52.4)4 (19.0)
 Mixed12 (14)0 (00.0)8 (66.7)4 (33.3)0.429
Lauren’s classification
 Intestinal53 (61.6)14 (26.4)30 (56.6)9 (17.0)
 Diffuse33 (38.4)3 (9.1)18 (54.5)12 (36.4)0.044